Fate Therapeutics (FATE) Net Margin (2016 - 2025)
Historic Net Margin for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to 1847.21%.
- Fate Therapeutics' Net Margin fell 2877200.0% to 1847.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 2270.21%, marking a year-over-year decrease of 9407300.0%. This contributed to the annual value of 1415.8% for FY2024, which is 11429900.0% down from last year.
- Fate Therapeutics' Net Margin amounted to 1847.21% in Q3 2025, which was down 2877200.0% from 1785.37% recorded in Q2 2025.
- Fate Therapeutics' Net Margin's 5-year high stood at 42.21% during Q1 2023, with a 5-year trough of 6236.23% in Q2 2023.
- Moreover, its 5-year median value for Net Margin was 594.45% (2024), whereas its average is 1475.7%.
- As far as peak fluctuations go, Fate Therapeutics' Net Margin crashed by -57922600bps in 2023, and later skyrocketed by 56417800bps in 2024.
- Quarter analysis of 5 years shows Fate Therapeutics' Net Margin stood at 404.74% in 2021, then surged by 66bps to 138.74% in 2022, then plummeted by -1778bps to 2605.07% in 2023, then dropped by -19bps to 3111.51% in 2024, then surged by 41bps to 1847.21% in 2025.
- Its Net Margin stands at 1847.21% for Q3 2025, versus 1785.37% for Q2 2025 and 2329.28% for Q1 2025.